These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

455 related articles for article (PubMed ID: 29490655)

  • 1. Adaptive designs in clinical trials: why use them, and how to run and report them.
    Pallmann P; Bedding AW; Choodari-Oskooei B; Dimairo M; Flight L; Hampson LV; Holmes J; Mander AP; Odondi L; Sydes MR; Villar SS; Wason JMS; Weir CJ; Wheeler GM; Yap C; Jaki T
    BMC Med; 2018 Feb; 16(1):29. PubMed ID: 29490655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adding flexibility to clinical trial designs: an example-based guide to the practical use of adaptive designs.
    Burnett T; Mozgunov P; Pallmann P; Villar SS; Wheeler GM; Jaki T
    BMC Med; 2020 Nov; 18(1):352. PubMed ID: 33208155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adaptive designs in clinical trials: from scientific advice to marketing authorisation to the European Medicine Agency.
    Collignon O; Koenig F; Koch A; Hemmings RJ; Pétavy F; Saint-Raymond A; Papaluca-Amati M; Posch M
    Trials; 2018 Nov; 19(1):642. PubMed ID: 30454061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Review of draft FDA adaptive design guidance.
    Cook T; DeMets DL
    J Biopharm Stat; 2010 Nov; 20(6):1132-42. PubMed ID: 21058109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adaptive designs undertaken in clinical research: a review of registered clinical trials.
    Hatfield I; Allison A; Flight L; Julious SA; Dimairo M
    Trials; 2016 Mar; 17(1):150. PubMed ID: 26993469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overview, hurdles, and future work in adaptive designs: perspectives from a National Institutes of Health-funded workshop.
    Coffey CS; Levin B; Clark C; Timmerman C; Wittes J; Gilbert P; Harris S
    Clin Trials; 2012 Dec; 9(6):671-80. PubMed ID: 23250942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stakeholder perspectives on adaptive clinical trials: a scoping review.
    Madani Kia T; Marshall JC; Murthy S
    Trials; 2020 Jun; 21(1):539. PubMed ID: 32552852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paradigms for adaptive statistical information designs: practical experiences and strategies.
    Wang SJ; Hung HM; O'Neill R
    Stat Med; 2012 Nov; 31(25):3011-23. PubMed ID: 22927234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adaptive methods: telling "the rest of the story".
    Emerson SS; Fleming TR
    J Biopharm Stat; 2010 Nov; 20(6):1150-65. PubMed ID: 21058111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attitudes and opinions regarding confirmatory adaptive clinical trials: a mixed methods analysis from the Adaptive Designs Accelerating Promising Trials into Treatments (ADAPT-IT) project.
    Meurer WJ; Legocki L; Mawocha S; Frederiksen SM; Guetterman TC; Barsan W; Lewis R; Berry D; Fetters M
    Trials; 2016 Jul; 17():373. PubMed ID: 27473126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adaptive design clinical trials: a review of the literature and ClinicalTrials.gov.
    Bothwell LE; Avorn J; Khan NF; Kesselheim AS
    BMJ Open; 2018 Feb; 8(2):e018320. PubMed ID: 29440155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cross-sector surveys assessing perceptions of key stakeholders towards barriers, concerns and facilitators to the appropriate use of adaptive designs in confirmatory trials.
    Dimairo M; Julious SA; Todd S; Nicholl JP; Boote J
    Trials; 2015 Dec; 16():585. PubMed ID: 26700741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adaptive methods: when and how should they be used in clinical trials?
    Porcher R; Lecocq B; Vray M;
    Therapie; 2011; 66(4):319-26, 309-17. PubMed ID: 21851793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interim decision making in seamless trial designs: An application in an adaptive dose-finding study in a rare kidney disease.
    Papachristofi O; Bornkamp B; Wright M; Friede T
    Pharm Stat; 2024; 23(1):20-30. PubMed ID: 37691560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can emergency medicine research benefit from adaptive design clinical trials?
    Flight L; Julious SA; Goodacre S
    Emerg Med J; 2017 Apr; 34(4):243-248. PubMed ID: 27793963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Understanding the FDA guidance on adaptive designs: historical, legal, and statistical perspectives.
    Liu Q; Chi GY
    J Biopharm Stat; 2010 Nov; 20(6):1178-219. PubMed ID: 21058114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adaptive Design: A Review of the Technical, Statistical, and Regulatory Aspects of Implementation in a Clinical Trial.
    Cerqueira FP; Jesus AMC; Cotrim MD
    Ther Innov Regul Sci; 2020 Jan; 54(1):246-258. PubMed ID: 32008232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A literature review of applied adaptive design methodology within the field of oncology in randomised controlled trials and a proposed extension to the CONSORT guidelines.
    Mistry P; Dunn JA; Marshall A
    BMC Med Res Methodol; 2017 Jul; 17(1):108. PubMed ID: 28720094
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 23.